Related Experiment Video
Updated: May 21, 2026

The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve
Published on: September 7, 2022
Prehabilitation before hip arthroscopy for femoroacetabular impingement syndrome: A randomised controlled trial
Min Li1, Chenyi Jiang2, Ruixin Wang3
1Department of Nursing, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Abstract:
DesignPragmatic, two-arm, parallel-group, superiority randomised controlled trial with assessor-blinding and statistician-blinding.SettingSingle orthopaedic centre in Shanghai, China.ParticipantsOne hundred and eighty adults (aged 18-50 years) with femoroacetabular impingement syndrome scheduled for hip arthroscopy were randomised to prehabilitation (n = 90) or usual care (n = 90).InterventionThe prehabilitation group received 6 weeks of supervised exercise, education and home activity before surgery. Controls received standard preoperative advice. All patients received identical postoperative rehabilitation.Main measuresThe primary outcome was the Harris Hip Score at 24 weeks. Secondary outcomes included pain, maximal hip muscle strength, range of motion, dynamic balance, quality of life, mental health and cost.ResultsAt 24 weeks, the Harris Hip Score did not differ significantly between groups (adjusted between-group difference 0.98 points [95% CI -0.11 to 2.07], p = 0.08). At 4 and 12 weeks, differences numerically favoured prehabilitation (1.52 points, uncorrected p = 0.02; 1.14 points, uncorrected p = 0.04) but did not reach significance after Bonferroni correction (threshold p < 0.0167). Secondary outcomes favoured prehabilitation, including pain, maximal hip strength, range of motion and dynamic balance, though all between-group differences were below published thresholds for clinically important change.ConclusionsPrehabilitation before hip arthroscopy for femoroacetabular impingement syndrome was associated with small early improvements that did not reach statistical significance for the primary outcome after correction for multiple comparisons and were below clinically important thresholds. Total costs did not differ significantly between groups.Trial registration numberChiCTR2500113298 (Chinese Clinical Trial Registry, https://www.chictr.org.cn/, date of registration: 26 November 2025). This trial was registered retrospectively.